Ireland
--:--IST
Latest
Clinical Trials in France / NCT07338110
Recruiting Observational

French Achilles Tendon Surgery Cohort Study

NCT07338110 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2023-04-01
Last updated
2026-03-19

Condition(s) studied

Achilles Injuries TendonSurgery

Investigational drug(s) / intervention(s)

Achilles Tendon Surgery

Achilles Tendon Surgery: Achilles tendon repair involves reattaching the torn ends of the tendon to restore its continuity and functional tension. This technique is typically used for acute ruptures where the tendon quality is preserved and direct suture is feasible. Achilles tendon reconstruction is performed in chronic ruptures, re-ruptures, or cases with significant tendon degeneration or retraction, where direct repair is not possible. The procedure may involve tendon transfers such as the flexor hallucis longus (FHL), or autografts from the triceps surae aponeurosis or hamstring tendons (gracilis-semitendinosus, DIDT). These techniques aim to restore tendon length, strength, and function. In some cases, augmentation techniques (e.g., pedicled or free grafts) are used to reinforce the repair, particularly in patients with poor tendon tissue quality or high functional demands.

Study summary

This 20-year prospective cohort study monitors patients following Achilles tendon repair to assess re-rupture rates, long-term functional outcomes, return-to-sport rates, and procedure-related complications. The aim is to better understand the long-term durability and clinical effectiveness of Achilles tendon repair techniques to optimize patient outcomes.

Eligibility

Sex
ALL
Min age
7 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing Achilles tendon repair surgery Exclusion Criteria: * Patient refusal

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chirurgie du Sport Paris Île-de-France Region Recruiting

More Chirurgie Du Sport trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07338110 on ClinicalTrials.gov ↗ ← All trials in France